Comments
Pharma major Dr Reddy's Laboratories has launched Duloxetine delayed release capsules in the US market. The anti-depressant drug is the generic equivalent of Cymbalta.
The brand and generic had a sales of $5 billion in the US in the 12 months ended April 2014, according to a release. The company’s scrip gained 1.93 per cent on the BSE on Friday to close at ₹2553.15.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.